2022-08-08
Adopted for San Diego "CONNECT" Acceleration Program
CoreTissue BioEngineering has been adopted for The Springboard™ Program in Yokohama, which is supported by Yokohama City and San Diego (CONNECT) in the United States. “The Springboard™ Program in Yokohama” is a program in which the city of Yokohama collaborates with San Diego-based accelerator “CONNECT” to foster and support startup companies in the life science field. Through this program, CoreTissue BioEngineering will accelerate the preparation for the U.S. market of artificial ligaments developed using decellularization technology.
2023-07-18
We obtained a license for manufacturing and marketing of first-class medical devices.
2023-04-07
CTBE Selected for AMED “Advanced Medical Devices and Systems Development Project”
2023-02-24
Notice of Completion of Series A Funding of Approximately 560 Million Yen
2023-02-16
Our CEO, Chiaki Waki presented at MedTech Woman’s Career Talk Event on February 6th, 2023
2023-01-28
Our CEO, Chiaki Waki will present at ”Yokohama Japan Health Tech and Wellness Startups Pitch Event” on January 31st 4pm to 6pm PST.